Amgen INC AMGEN ORD (CDI)/ US0311621009 /
4/25/2024 7:06:01 PM | Chg. - | Volume | Bid5:35:23 PM | Ask5:35:23 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
268.25USD | - | 2,462 Turnover: 173,778.10 |
-Bid Size: - | -Ask Size: - | 142.02 bill.USD | 3.27% | 21.04 |
GlobeNewswire
8/29/2024
Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...
GlobeNewswire
8/28/2024
Prevent Cancer Annual Gala to celebrate three decades of commitment to cancer prevention and early d...
GlobeNewswire
8/15/2024
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...
GlobeNewswire
8/12/2024
TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
8/8/2024
CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
8/8/2024
Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
GlobeNewswire
8/5/2024
Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors
GlobeNewswire
8/1/2024
CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024